Literature DB >> 789015

European experience with prenatal diagnosis of congenital disease: a survey of 6121 cases.

H Galjaard.   

Abstract

The results of 6121 prenatal diagnoses established by 46 centers in eight West-European countries are reported. The percentage of "spontaneous" abortions following early amniocentesis (1.4%) does not seem to exceed the normal rate of spontaneous abortion in this period of pregnancy. A total of nearly 300 affected fetuses was detected, and in all but 5 instances the parents asked for interruption of the pregnancy. The majority of prenatal monitoring (75%) was carried out because of an increased risk of chromosomal aberration. In the group with higher maternal age 2.8% of the fetuses were affected; this figure was 4.6% for mothers older than 38 years. Monitoring because of an earlier child with trisomy 21 showed 1.3% fetuses with a chromosomal aberration, and 1.7% abnormal karyotypes were detected in the group where amniocentesis was performed for "miscellaneous reasons." In pregnancies where a parental translocation has been demonstrated, 6.7% of the fetuses showed an unbalanced karyotype and 25% were balanced carriers. Also discussed are results and organizatioal problems of prenatal monitoring for inherited metabolic disorders (206 analyses for 23 different enzyme defects) and for neural tube defects (about 2700 cases).

Entities:  

Mesh:

Year:  1976        PMID: 789015     DOI: 10.1159/000130663

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  12 in total

Review 1.  Prenatal diagnosis: the medical genetics perspective. Ethics and Public Policy Committee, Canadian College of Medical Geneticists.

Authors: 
Journal:  CMAJ       Date:  1991-05-01       Impact factor: 8.262

2.  A survey on prenatal diagnosis of inherited metabolic diseases in Japan.

Authors:  K Tada; J Aikawa; Y Igarashi; K Hayasaka; K Narisawa; M Owada; T Kitagawa
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Sixteen years' experience of counselling, diagnosis, and prenatal detection in one genetic centre: progress, results, and problems.

Authors:  P E Polani; E Alberman; B J Alexander; P F Benson; A C Berry; S Blunt; M G Daker; A H Fensom; D M Garrett; V M McGuire; J A Roberts; M J Seller; J D Singer
Journal:  J Med Genet       Date:  1979-06       Impact factor: 6.318

4.  Amniocentesis in the West Midlands: report on 1000 births.

Authors:  T Webb; J H Edwards; A H Cameron; J M Crawley; M Hulten; D I Rushton; R A Thompson
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

5.  Outcome of pregnancy after amniocentesis for chromosome analysis.

Authors:  J Philip; J Bang
Journal:  Br Med J       Date:  1978-10-28

6.  Should the indications for prenatal chromosome analysis be changed?

Authors:  J D Steven; J B Scrimgeour
Journal:  Br Med J       Date:  1978-02-04

7.  Hazards of amniocentesis.

Authors: 
Journal:  Br Med J       Date:  1978-12-16

8.  Enhancement of human amniotic cell growth by Ficoll-Paque gradient fractionation.

Authors:  H C Chang; O W Jones; C Bradshaw; S Sarkar; R P Porreco
Journal:  In Vitro       Date:  1981-01

9.  Reciprocal translocation with special reference to reproductive failure.

Authors:  I Subrt
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

10.  Prenatal diagnosis of a de novo Y/22 translocation.

Authors:  M Verjaal; P E Treffers; Y Nagal; N J Leschot
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.